Ha Medicine ? Four domestic Antibiotic Raw material base, the current income of
antibiotics accounted for nearly 30% of the main production of penicillin and
Cephalosporin Two series more than 30 species; capacity 3,500 tons, the domestic
industry ranked second antibiotic, product market share, with scale advantages.
North China Pharmacy Main products are penicillin, semi-synthetic penicillin,
streptomycin, tetracycline, lincomycin, Vitamin B 12 and so on. Among the
antibiotics industry leader. In 2001 a number of the first in domestic market share;
penicillin G raw materials 37.27%, 37.29% of raw materials Cephradine, Sulfuric acid
71.15% streptomycin raw materials, Vitamin C Materials 19.91%, 91.74% vitamin
B12 material. Goals - sit tight in the China and the world of antibiotics API The leader
Lukang Pharmaceutical Penicillin series ,6-A PA Series, the current total production
capacity in tons or more, the company is currently the only antibiotic also has three
nucleus 6-APA ,7-ADCA ,7-ACA production technology of pharmaceutical base.
Tianyaogufen Cortex hormones bulk drugs, the first domestic production, in
technology and production process, with the absolute Competition Advantage.
Domestic energy production of 20 kinds of bulk drugs in the cortical hormones, the
company's annual production of 17 varieties, including 16 varieties took the lead in
developing production lines, there are seven varieties of exclusive lines of domestic
production, dehydrogenase cortisone, hydrocortisone pine, dexamethasone acetate,
fluocinolone acetate in 11 varieties were products of international standard certificate.
Annual production capacity of 100 tons in 1999, corticosteroids production of bulk
drugs accounted for more than 44% of the country. Dexamethasone products currently
account for 90% of the domestic market share above and outside of China for more
than 50% of the Asian market and has entered the European market, which accounts
for ag products Sell The amount of 50%, 70% of profits.
Zhejiang Medicine Main production fluoroquinolone antibiotics, vitamin E and other
chemical raw three categories. Vitamin E production capacity, technology and export
are among the country's first. Vitamin E plans to expand production to 4,500 tons,
while capable of producing 200 tons of natural vitamin E.
Northeast Pharmaceutical Domestic vitamin C within the industry, the current
production capacity 11000-15000 tons, with production capacity and scale of
Xinhua Pharmaceutical Produces anti-inflammatory drugs (mainly dipyrone,
Aspirin , Aminopyrine, isopropyl antipyrine, ibuprofen), drugs are an annual output of
15,000 tons of raw materials (including export of 8,000 tons), phenobarbital, Amytal,
pipemidic acid, dipyrone, aminopyrine , antipyrine, aspirin, and Coffee Market share
due to other chemical raw ranked first in the country.
Hisun Pharmaceutical Anti- Cancer API to export-oriented, is the largest
manufacturer of antibiotic antineoplastic agents, the company strong scientific
research strength, products with high technical content, but the initiative in market
development capacity is not strong.
Anti-tumor drug raw materials, the total annual production capacity of 50 tons of
bulk drugs. Produced by antineoplastic agents have Etoposide (VP16), ifosfamide,
Mesna, letrozole, irinotecan, leucovorin, methotrexate, oxaliplatin, cyclophosphamide
APIs and Preparation , In colorectal cancer therapy in the dominant role. Is the key
state of anticancer drug research and production base, oncology sales among the best
in the country.
I am China Quality Digital writer, reports some information about baby stroller
carseat , baby pouch carrier.